Alastair McGregor - Concepedia

Author

Alastair McGregor

Also Known As

A McGregor, A Mcgregor, A. C. McGregor, A. McGregor, A. Mcgregor, Adam Finn, Ailsa McGregor, Alastair C McGregor, Alastair C. McGregor, Alastair C. Mcgregor

Publications

11.5K

Citations

H-Index

Concepts

All Affiliations

University College London London North West Healthcare NHS Trust Public Health England University of Oxford Imperial College London

About

Alastair McGregor is an author at University College London specializing in medicine, immunology, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	326
2	Immunology	3	3	226
3	Allergy	2	2	189
4	Cell Biology	1	1	100
5	Molecular Biology	1	1	100

Alastair McGregor

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, The Lancet	2021	649
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin, The Lancet	2021	253
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial Alasdair Munro, Shuo Feng, Leila Janani, The Lancet Infectious Diseases	2022	170
Studies on the host-parasite relationship in Schistosoma mansoni-infected mice: the immunological dependence of parasite egg excretion. Michael J. Doenhoff, R. Musallam, J. Bain, PubMed Schistosoma MansoniParasitic DiseaseParasite InteractionsImmunologyImmune Regulation	1978	104
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London Liyang Wang, Amit Amin, Priya Khanna, Journal of Antimicrobial Chemotherapy	2020	103
Multiple Interactions Control the Intracellular Localization of the Herpes Simplex Virus Type 1 Capsid Proteins Frazer J. Rixon, Clare Addison, Alastair McGregor, Journal of General Virology Capsid AssemblyHsv-1 CapsidVirus StructureViral ReplicationMolecular Virology	1996	100
Schistosoma Mansoni Infections in T-cell Deprived Mice, and the Ameliorating Effect of administering Homologous Chronic Infection Serum Michael J. Doenhoff, R. Musallam, J. Bain, American Journal of Tropical Medicine and Hygiene	1979	99
Factors affecting the acquisition of resistance against <i>Schistosoma mansoni</i> in the mouse. I. Demonstration of resistance to reinfection using a model system that involves perfusion of mice within three weeks of challenge Michael J. Doenhoff, Q. D. Bickle, E. Long, Journal of Helminthology Disease ResistanceParasitic DiseaseAllergyPathogenesisImmunology	1978	85

Page 1